Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Merrimack Announces Timing of Second Quarter 2017 Investor Conference Call

Merrimack Pharmaceuticals,Inc.
Posted on: 02 Aug 17
Merrimack Announces Timing of Second Quarter 2017 Investor Conference Call

PR Newswire

CAMBRIDGE, Mass., Aug. 2, 2017

CAMBRIDGE, Mass., Aug. 2, 2017 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) today announced that the company will host its second quarter 2017 investor conference call and webcast at 8:30 am ET on Wednesday, August 9, 2017.  

The call will cover an update on Merrimack's recent progress as well as a summary of second quarter 2017 financial results. A press release detailing the information to be discussed on the call will be issued the morning of Wednesday, August 9, 2017. Investors and the general public are invited to listen to the call by dialing (877) 564-1301 (domestic) or (224) 357-2394 (international) five minutes prior to the start of the call and providing the passcode 56140335.

A listen-only webcast of the call will be available in the Investors section of Merrimack's website, investors.merrimack.com, and a replay of the call will be archived there for six weeks.

About Merrimack

Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart design and development of targeted solutions based on the deep understanding of cancer pathways and biological markers. All of Merrimack's product candidates, including three in clinical studies and several others in preclinical development, fit into its strategy of 1) understanding the biological problems it is trying to solve, 2) designing specific solutions and 3) developing those solutions for biomarker-selected patients. This three-pronged strategy seeks to ensure optimal patient outcomes. For more information, please visit Merrimack's website at www.merrimack.com.

Forward-Looking Statements

Any statements in this press release about future expectations, plans and prospects for Merrimack constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, as amended. Actual results may differ materially from those indicated by such forward-looking statements. Merrimack anticipates that subsequent events and developments will cause its views to change. However, while Merrimack may elect to update these forward-looking statements at some point in the future, Merrimack specifically disclaims any obligation to do so.

CONTACT:

Geoffrey M. Grande, CFA
617-441-7602
ggrande@merrimack.com

View original content:http://www.prnewswire.com/news-releases/merrimack-announces-timing-of-second-quarter-2017-investor-conference-call-300497754.html

SOURCE Merrimack Pharmaceuticals, Inc.

PR Newswire
www.prnewswire.com

Last updated on: 02/08/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.